Disparities in HIV Care: The Mounting Epidemic Plaguing African Americans
Premiere Date: Monday, April 26, 2021This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- ABIM (MOC)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, April 26, 2022
Note: Credit Is No Longer Available
 | Oni J. Blackstock, MD, MHS (Moderator) Founder and Executive Director Health Justice, LLC New York, NY |
 | Carlos Malvestutto, MD, MPH Associate Professor Division of Infectious Diseases Department of Medicine Ohio State University Wexner Medical Center Columbus, OH |
 | Leandro A. Mena, MD, MPH Chair and Professor of Population Health Science Professor of Medicine, Division of Infectious Diseases University of Mississippi Medical Center Jackson, MS |
The national response to HIV infection and advances in preventative therapies has meant that there are fewer new HIV infections nationally. Additionally, more people with HIV are diagnosed, on a treatment regimen, and leading longer, healthier lives. However, stark racial disparities remain for people living with HIV. Black and African Americans do not engage in more high-risk behaviors than persons of other races, yet they have the highest rates of new HIV infections. Black and African Americans also have poorer outcomes for diagnosis, linkage to care, retention in care, antiretroviral therapy (ART), treatment adherence, and viral suppression, which has led them to be the most affected population of new HIV diagnoses.
This CME Outfitters Live and OnDemand will address racial and ethnic health care disparities among at-risk individuals, with expert faculty discussing best practices for actively engaging Black/African Americans at risk for HIV, developing treatment strategies for older adults with HIV, and initiating and switching patients to ART based on safety and efficacy profiles, to optimize health and treatment outcomes throughout their lives.
At the end of this CE activity, participants should be able to:
- Actively engage Black/African Americans at risk for HIV in testing, treatment, and educational initiatives.
- Develop treatment strategies for older adults with HIV to optimize health outcomes.
- Integrate best practices for initiating and switching patients to ART based on safety and efficacy profiles.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Summarize ways to actively engage Black/African Americans at risk for HIV in testing, treatment, and educational initiatives.
- Explain treatment strategies for older adults with HIV to optimize health outcomes.
- Identify best practices for initiating and switching patients to ART based on safety and efficacy profiles.
This educational activity is supported by independent educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare. These supporters were not involved in the development of content or selection of faculty for this educational activity.
Primary care physicians, infectious disease specialists, nurse practitioners, PAs, nurses, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Enduring: 0376-0000-21-062-H02-P
Type: Knowledge-based
ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Formats
Enduring material
Royal College MOC: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to PAs: PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Blackstock reports that she is on the speakers bureau for ClinicalMind.
Dr. Malvestutto reports that he is on the advisory board for ViiV Healthcare.
Dr. Mena reports that he receives grants from Gilead Sciences, Inc. and Merck & Co. He receives research support from Binx Health, Inc.; Gilead Sciences, Inc.; GlaxoSmithKline/ViiV Healthcare; Merck & Co.; and ThaiMed. He is on the speakers bureau for Gilead Sciences, Inc. He is a consultant for Gilead Sciences, Inc.; GlaxoSmithKline/ViiV Healthcare; and Merck & Co.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Noreen Iftikhar, MD (planning committee) has no disclosures to report.
Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
TV-128-042621-90
